EUROPEAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2024-01-15 ms6000001244498457 来自北京

偏重的研究方向：肿瘤;肿瘤免疫
经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?

132 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2022-06-17 Furion

精彩评论，需要您登录查看

175 2

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2023-02-19 1e1d9025m73(暂无匿称) 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤;临床
经验分享：投稿1个多月了，还是under review, 心理焦急

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2021-10-18 喵了个咪5371

投稿一个月还是with editor，这是什么情况啊

105 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2021-12-29 rayms

为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？

78 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2020-08-27 123d981cm08(暂无昵称)

请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal

167 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2019-09-11 于小鱼小鱼

请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表::
研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表:
with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。

long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。

188 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2024-03-15 ms6000000136446040 来自上海

偏重的研究方向：肿瘤
经验分享：2.27投稿，3.15拒稿

10 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2023-02-13 ms5000000259255905 来自北京

偏重的研究方向：肿瘤临床研究
经验分享：一个肝母细胞瘤的research，都两周了还是with editor

64 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2181884, encodeId=af9721818848a, content=偏重的研究方向：肿瘤;肿瘤免疫 经验分享：with editor 2周，进入decsion in process流程，是要凉凉了吗请问?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Mon Jan 15 21:53:20 CST 2024, time=2024-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1226976, encodeId=346f12269e6e1, content=偏慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/20220617/0bc40513e97d4571b2ce7697679edaeb.jpeg, type=image, width=828, height=690)], authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/08/c97f2f161c178f10c0209678bc1a384d.jpg, createdBy=f0722218875, createdName=Furion, createdTime=Fri Jun 17 09:30:01 CST 2022, time=2022-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115404, encodeId=4330211540423, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤;临床 经验分享：投稿1个多月了，还是under review, 心理焦急, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43942005316, createdName=1e1d9025m73(暂无匿称), createdTime=Sun Feb 19 15:13:45 CST 2023, time=2023-02-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1061445, encodeId=819c106144596, content=投稿一个月还是with editor，这是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210713/d622df96f8c041cca53c49cabf17ed1d/41be18fc47f84d25bf15563c7d70a5be.jpg, createdBy=97772470812, createdName=喵了个咪5371, createdTime=Mon Oct 18 11:56:45 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090219, encodeId=fc96109021943, content=为什么我认为我的文章只有3-4分，但导师要从7分以上开始投？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Wed Dec 29 14:52:48 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813757, encodeId=aa81813e5748, content=请问有哪位老师最近状态有改变吗？投稿一周多还是submited to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd872442293, createdName=123d981cm08(暂无昵称), createdTime=Thu Aug 27 08:07:53 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576193, encodeId=8b085e619335, content=请问with editor 后直接decision in process的意思就是不送外审了嘛？long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。long7832 2017-03-23 16:06:00 发表: with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, beContent=long7832 2017-03-23 发表:: 研究方向：肿瘤; 接收率：约25% 审稿时间：约1个月 SCI(2015)：6.163 SCI(2014)：5.417 with editor8天直接decision in process，到现在decision又8天了还没消息，搞不懂怎么回事。如果拒了为啥不直接干脆点，耽误时间。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/27/3d8d7dbcfa2e6ecba02d12f8b9e7585b.jpg, createdBy=a5182169013, createdName=于小鱼小鱼, createdTime=Wed Sep 11 00:00:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193317, encodeId=51d0219331ead, content=偏重的研究方向：肿瘤 经验分享：2.27投稿，3.15拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=109a8327611, createdName=ms6000000136446040, createdTime=Fri Mar 15 09:16:46 CST 2024, time=2024-03-15, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2114316, encodeId=16e5211431683, content=偏重的研究方向：肿瘤临床研究 经验分享：一个肝母细胞瘤的research，都两周了还是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Mon Feb 13 00:11:33 CST 2023, time=2023-02-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1217592, encodeId=6c8f121e5922d, content=想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90ac5489842, createdName=ms8000001880702144, createdTime=Sat May 07 12:01:23 CST 2022, time=2022-05-07, status=1, ipAttribution=)]

2022-05-07 ms8000001880702144

想问一下大家，是需要所有作者同意才会with editor嘛？已经投稿一周了，还没有分配稿号，这正常吗？

64 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务